Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2987457015 | Dabigatran etexilate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| 2987480011 | Dabigatran etexilate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dabigatran etexilate (substance) | Is a | Pyridine and/or pyridine derivative | true | Inferred relationship | Some | ||
| Dabigatran etexilate (substance) | Is a | Anticoagulant (substance) | true | Inferred relationship | Some | ||
| Dabigatran etexilate (substance) | Is a | Substance categorized by disposition | true | Inferred relationship | Some | ||
| Dabigatran etexilate (substance) | Has disposition (attribute) | Disposition | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 110 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | True | Dabigatran etexilate (substance) | Inferred relationship | Some | 1 |
| Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 150 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | True | Dabigatran etexilate (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR